medigraphic.com
Colegio de Medicina Interna de México.

2020, Number 3

<< Back Next >>

Med Int Mex 2020; 36 (3)

From 2019-nCoV to COVID-19, characterizing the disease

del Carpio-Orantes L

Language: Spanish
References: 15
Page: 414-417
PDF size: 215.20 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Real-time map of coronavirus cases by Johns Hopkins School http://cvoed.imss.gob.mx/mapa_coronavirus/

  2. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. DOI: 10.1056/NEJMoa2001017.

  3. Rodríguez-Morales AJ, MacGregor K, Kanagarajah S, Patel D, Schlagenhauf P. Going global – Travel and the 2019 novel coronavirus. Travel Medicine and Infectious Disease 101578. doi:10.1016/j.tmaid.2020.101578.

  4. Rodriguez-Morales AJ, Bonilla-Aldana DK, Balbin-Ramon GJ, et al. History is repeating itself, a probable zoonotic spillover as a cause of an epidemic: the case of 2019 novel Coronavirus. Infez Med 2020;28(1):3-5.

  5. Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020 January 24 (Epub ahead of print). https://doi.org/10.1016/S0140-6736(20)30154- 9.

  6. Phan LT, Nguyen TV, Luong QC, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. DOI: 10.1056/NEJMc2001272.

  7. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med 2020 doi 10.1056/NEJMc2001468.

  8. Favre G, Pomar L, Musso D, Baud D. 2019-nCoV epidemic: what about pregnancies? [published online ahead of print, 2020 Feb 6]. Lancet 2020;S0140-6736(20)30311-1. doi:10.1016/S0140-6736(20)30311-1.

  9. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020. DOI: 10.1056/NEJMoa2001191.

  10. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res (2020). https://doi. org/10.1038/s41422-020-0282-0.

  11. Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature review drug discovery. 10 february 2020. doi: 10.1038/d41573-020-00016-0.

  12. Negahdaripour M. The battle against COVID-19: Where do we stand now? Iran J Med Sci 2020;45(2):82-82. doi: 10.30476/ijms.2020.46357.

  13. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a Report of 72,314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print, 2020 Feb 24]. JAMA 2020;10.1001/jama.2020.2648. doi:10.1001/ jama.2020.2648.

  14. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez- Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera- Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ramírez-Vallejo E, Suárez JA, Zambrano LI, Villamil-Gómez WE, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R. Clinical, Laboratory and Imaging Features of COVID-19: A Systematic Review and Meta-analysis. Preprints 2020, 2020020378. doi: 10.20944/preprints202002.0378.v1.

  15. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China [published online ahead of print, 2020 Feb 28]. N Engl J Med 2020;10.1056/NEJMoa2002032. doi:10.1056/NEJMoa2002032.




2020     |     www.medigraphic.com